Codiak BioSciences, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
CDAKQ on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
35 Cambridgepark Drive, Suite 500, Cambridge, Massachusetts

There are no Buy or Sell transactions made by insiders since 8/21/2023

Codiak BioSciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ARCH Venture Fund VIII, L.P. 10%+ Owner Sep 13, 2022
Flagship Ventures Fund V General Partner LLC 10%+ Owner Sep 15, 2022
Steven Gillis Director Feb 16, 2023
Anne-Virginie Eggimann Director Jun 17, 2022
Linda Bain Chief Financial Officer Mar 28, 2023
David J. Mauro Chief Medical Officer Jan 24, 2023
Karen Bernstein Director Feb 16, 2023
Jennifer J. Wheler Chief Medical Officer May 10, 2021
Sriram Sathyanarayanan Chief Scientific Officer Mar 29, 2023
Jason Haddock Director Feb 16, 2023
Arundathy N. Pandite Director Jun 17, 2022
Konstantin Konstantinov Chief Technology Officer Mar 28, 2023
Kyriazi Theo Melas Director Feb 16, 2023
Benny Sorensen Former SVP, Clinical Development Jun 8, 2021
Nicole Barna Senior Vice President, Human Resources Mar 29, 2023
Yalonda Howze Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary Mar 30, 2023
Richard Brudnick Officer title: Chief Business Officer and Head of Corporate Strategy Feb 16, 2022
Douglas E. Williams President & CEO, Director Mar 28, 2023
Cooney Charles L Director Feb 16, 2023

Recent Insider Transactions by Companies or Individuals for Codiak BioSciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.